Consistent with previous findings showing that glycolysis promotion in effector T cells is a cause of severe colitis (Macintyre et al., 2014), LysoPS exaggerates large intestinal inflammation by fueling glycolysis in IFN-γ–producing CD4+ T cells. The gene discussed is IFNG; the disease is colitis.